Microtips Technology Inc. (3285.TWO)
TWD 27.1
(-0.73%)
TWD 27.1
(-0.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 118.05 Million | 77.1 Million | -89.56 Million | 20.14 Million | - |
| Net Income | 54.05 Million | -9.71 Million | 10 Million | 41.57 Million | - |
| Depreciation & Amortization | 17.52 Million | 19.46 Million | 17.95 Million | 19.08 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | -240 Thousand | - |
| Change in working capital | 82.49 Million | 16.06 Million | -116.34 Million | -24.41 Million | - |
| Other non-cash items | -10.46 Million | -1.61 Million | 645 Thousand | -771 Thousand | - |
| Investing Cash Flow | -45.54 Million | -9.49 Million | -10.48 Million | 62.7 Million | - |
| Investments in PPE | -1.15 Million | -34.72 Million | -17.17 Million | -2.13 Million | - |
| Acquisitions | 26 Thousand | - | - | - | - |
| Investment purchases | -55.36 Million | -9.09 Million | - | -37.66 Million | - |
| Sales/Maturities of investments | - | 29.82 Million | 1.98 Million | 98.26 Million | - |
| Other Investing Activities | 284 Thousand | -81 Thousand | 771 Thousand | 378 Thousand | - |
| Financing Cash Flow | -99.63 Million | -34.63 Million | 38.22 Million | -24.29 Million | - |
| Debt repayment | -80 Million | -19.54 Million | -66.37 Million | -2.21 Million | - |
| Dividends payments | - | - | -14.95 Million | -8.54 Million | -51.28 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -7.87 Million | -3.11 Million | -1.73 Million | -1.4 Million | - |
| Accounts receivables | 94.61 Million | - | - | - | - |
| Accounts payables | -14.35 Million | - | - | - | - |
| Inventory | 9.78 Million | 26.4 Million | -50.72 Million | -39.37 Million | - |
| Other working capital | -21.9 Million | - | - | - | - |
| Cash at beginning of period | 430.68 Million | 391.61 Million | 454.69 Million | 397.05 Million | - |
| Cash at end of period | 402.59 Million | 430.68 Million | 391.61 Million | 454.69 Million | - |
| Capital Expenditure | -1.15 Million | -34.72 Million | -17.17 Million | -2.13 Million | - |
| Effect of forex changes on cash | -964 Thousand | 6.1 Million | -1.25 Million | -909 Thousand | - |
| Net cash flow / Change in cash | -28.09 Million | 39.07 Million | -63.07 Million | 57.63 Million | - |
| Free Cash Flow | 116.9 Million | 42.37 Million | -106.73 Million | 18.01 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.52 Million | 18.65 Million | 7.93 Million | 54.05 Million | 22.61 Million | 29.54 Million |
| Depreciation & Amortization | 3.67 Million | 3.63 Million | 4.15 Million | 17.52 Million | 4.35 Million | 4.43 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.42 Million | -20.34 Million | -16.92 Million | 82.49 Million | 14.47 Million | 73.66 Million |
| Other non-cash items | -2.86 Million | -2.41 Million | -2.93 Million | -10.46 Million | -3.18 Million | -2.66 Million |
| Investing Cash Flow | 72.9 Million | -2.75 Million | 6.35 Million | -45.54 Million | -1.52 Million | -62.06 Million |
| Investments in PPE | -110 Thousand | -1.2 Million | -832 Thousand | -1.15 Million | -258 Thousand | -30 Thousand |
| Acquisitions | 2000.00 | - | - | - | - | - |
| Investment purchases | 3.41 Million | -3.41 Million | 3.92 Million | -55.36 Million | -3.11 Million | -56.17 Million |
| Sales/Maturities of investments | 63.61 Million | - | - | - | - | -8.73 Million |
| Other Investing Activities | 15 Thousand | 186 Thousand | 89 Thousand | 284 Thousand | -172 Thousand | 56 Thousand |
| Financing Cash Flow | -3.84 Million | -3.89 Million | -42.76 Million | -99.63 Million | -38.97 Million | -12.97 Million |
| Debt repayment | -454 Thousand | - | -39.87 Million | -80 Million | -30.06 Million | -10 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.77 Million | -1.89 Million | -138 Thousand | -7.87 Million | -5.88 Million | - |
| Accounts receivables | -46.15 Million | - | - | - | - | - |
| Accounts payables | 19.26 Million | - | - | - | - | - |
| Inventory | 9.06 Million | -6.63 Million | -32 Thousand | 9.78 Million | 4.89 Million | -5.98 Million |
| Other working capital | 10.94 Million | - | - | - | - | - |
| Cash at beginning of period | 405.24 Million | 402.59 Million | 467.01 Million | 430.68 Million | 459.55 Million | 449.12 Million |
| Cash at end of period | 471.4 Million | 405.24 Million | 402.59 Million | 402.59 Million | 467.01 Million | 459.55 Million |
| Capital Expenditure | -110 Thousand | -1.2 Million | -832 Thousand | -1.15 Million | -258 Thousand | -30 Thousand |
| Effect of forex changes on cash | -112 Thousand | 5.88 Million | -7.36 Million | -964 Thousand | 6.21 Million | 1.18 Million |
| Net cash flow / Change in cash | 66.15 Million | 2.65 Million | -64.42 Million | -28.09 Million | 7.46 Million | 10.42 Million |
| Free Cash Flow | -2.9 Million | 2.22 Million | -21.49 Million | 116.9 Million | 41.49 Million | 84.25 Million |
OCFC
INFY
HVRRY
BAMKF
QTRHF
GSK